Literature DB >> 1407587

Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type.

C DeCarli1, J V Haxby, J A Gillette, D Teichberg, S I Rapoport, M B Schapiro.   

Abstract

We determined the rates of lateral ventricular enlargement and decline in cognitive performance for 11 men and nine women with dementia of the Alzheimer type (DAT), and compared these rates with the same measures obtained for age-matched healthy controls (nine men and eight women). DAT patients, as a group, had only mild cognitive impairment at initial evaluation, and each patient was followed from 9 months to over 7 years with yearly evaluations. Six DAT patients had isolated memory impairment as their only cognitive deficit early in the course of the disease. The rate of total lateral ventricle enlargement (cm3/yr) was significantly different between DAT and healthy controls, and was more specific and sensitive to the diagnosis of DAT than comparison of cross-sectional volumes at final evaluation. The rate of total lateral ventricular enlargement did not differ significantly by patient sex, ventricular size at initial evaluation, age, or degree of cognitive impairment as measured by Mini Mental State Examination scores. However, in the six DAT patients initially found to have isolated memory impairment, the rate of ventricular enlargement during the period of isolated memory impairment was significantly less than the rate of ventricular enlargement after the onset of nonmemory cognitive impairment. The diagnostic power of total lateral ventricular measures made from two CTs separated by 1 year and obtained early in the course of the illness, however, was only 0.33. We conclude that the total lateral ventricular enlargement accompanying DAT is due to continuous, pathologic cell loss, significantly greater than cell loss due to the healthy aging process.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1407587     DOI: 10.1212/wnl.42.10.2029

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Authors:  C R Jack; M Slomkowski; S Gracon; T M Hoover; J P Felmlee; K Stewart; Y Xu; M Shiung; P C O'Brien; R Cha; D Knopman; R C Petersen
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

Review 2.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

3.  Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn C Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

4.  Discovering modes of an image population through mixture modeling.

Authors:  Mert R Sabuncu; Serdar K Balci; Polina Golland
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

5.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

Review 6.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

7.  Impaired visuomotor generalization by inconsistent attentional contexts.

Authors:  Tony S L Wang; Joo-Hyun Song
Journal:  J Neurophysiol       Date:  2017-06-28       Impact factor: 2.714

8.  Ventricular volume and dementia progression in the Cardiovascular Health Study.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn Cidis Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Neurobiol Aging       Date:  2006-02-28       Impact factor: 4.673

9.  Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; B F Boeve; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

10.  Callosal microstructural abnormalities in Alzheimer's disease and alcoholism: same phenotype, different mechanisms.

Authors:  Anne-Lise Pitel; Sandra Chanraud; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2010-09-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.